β 受体阻滞剂
Beta blockers | |
---|---|
药物种类 | |
ATC | C07 |
MeSH | D000319 |
AHFS/Drugs.com | 药物 |
Best Buy Drugs | |
WebMD | medicinenet rxlist |
醫療 用途
编辑
心臟 衰 竭
编辑
急性 心 肌 梗塞
编辑
高血壓
编辑
於2014
於2017
焦慮
编辑
手術
编辑
不良 影響
编辑
較不
禁忌 症 及注意 事項
编辑
氣 喘
编辑
糖尿 病
编辑
甲狀腺 亢進
编辑
心 搏過緩 或 房 室 傳導 阻滯
编辑
毒性
编辑
β 腎 上 腺 素 受體拮抗 作用
编辑
血 腦 屏 障 通 透 性
编辑
歷史
编辑
社會 與 文化
编辑
於2020
參 見
编辑
參考 文獻
编辑
- ^
李 海 瑞 ,彭伟,巫 少 荣.β 受体阻滞剂在中 青年 高 血 压中的 应用.中国 全科 医学 ,2023,26(02):248-254. DOI:10.12114/j.issn.1007-9572.2022.0527 - ^ 钱学贤.
β 受体阻断剂在慢性 充血 性 心力 衰 竭的应用[J].中国 循环杂志, 1999, 14(6):2.DOI:CNKI:SUN:ZGXH.0.1999-06-038. - ^ Freemantle N, Cleland J, Young P, Mason J, Harrison J. beta Blockade after myocardial infarction: systematic review and meta regression analysis. BMJ. June 1999, 318 (7200): 1730–1737. PMC 31101 . PMID 10381708. doi:10.1136/bmj.318.7200.1730.
- ^ James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. February 2014, 311 (5): 507–520. PMID 24352797. doi:10.1001/jama.2013.284427 .
- ^ 5.0 5.1 5.2 Frishman WH, Cheng-Lai A, Nawarskas J (编). Beta-Adrenergic Blockers. Current Cardiovascular Drugs. Current Science Group. 2005 [2010-09-07]. ISBN 978-1-57340-221-7.
- ^ 6.0 6.1 6.2 Barranger K, Vivian E, Peterson AM. Hypertension. Arcangelo VP, Peterson AM (编). Pharmacotherapeutics for advanced practice: a practical approach. Lippincott Williams & Wilkins. 2006: 205 [2010-09-07]. ISBN 978-0-7817-5784-3. (
原始 内容 存 档于2023-01-14). - ^ Clément K, Vaisse C, Manning BS, Basdevant A, Guy-Grand B, Ruiz J, et al. Genetic variation in the beta 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. The New England Journal of Medicine. August 1995, 333 (6): 352–354. PMID 7609752. doi:10.1056/NEJM199508103330605 .
- ^ Wiysonge CS, Bradley HA, Volmink J, Mayosi BM, Opie LH. Beta-blockers for hypertension. The Cochrane Database of Systematic Reviews. January 2017, 1 (1): CD002003. PMC 5369873 . PMID 28107561. doi:10.1002/14651858.CD002003.pub5.
- ^ Reinhart, Marcia; Puil, Lorri; Salzwedel, Douglas M.; Wright, James M. First-line diuretics versus other classes of antihypertensive drugs for hypertension. The Cochrane Database of Systematic Reviews. 2023-07-13, 2023 (7): CD008161. ISSN 1469-493X. PMC 10339786 . PMID 37439548. doi:10.1002/14651858.CD008161.pub3.
已 忽 略 未知 参 数 |pmc-embargo-date=
(帮助) - ^ Zhu J, Chen N, Zhou M, Guo J, Zhu C, Zhou J, et al. Calcium channel blockers versus other classes of drugs for hypertension. The Cochrane Database of Systematic Reviews. January 2022, 1 (1): CD003654. PMC 8742884 . PMID 35000192. doi:10.1002/14651858.CD003654.pub6.
- ^ Wiysonge CS, Bradley HA, Volmink J, Mayosi BM, Opie LH. Beta-blockers for hypertension. The Cochrane Database of Systematic Reviews. January 2017, 1 (1): CD002003. PMC 5369873 . PMID 28107561. doi:10.1002/14651858.cd002003.pub5.
- ^ Opie LH. Drugs for the Heart. Philadelphia: Saunders. 2009: 6–18. ISBN 978-1-4160-6158-8.
- ^ Hjalmarson A, Goldstein S, Fagerberg B, Wedel H, Waagstein F, Kjekshus J, et al. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group. JAMA. March 2000, 283 (10): 1295–1302. PMID 10714728. doi:10.1001/jama.283.10.1295 .
- ^ Leizorovicz A, Lechat P, Cucherat M, Bugnard F. Bisoprolol for the treatment of chronic heart failure: a meta-analysis on individual data of two placebo-controlled studies—CIBIS and CIBIS II. Cardiac Insufficiency Bisoprolol Study. American Heart Journal. February 2002, 143 (2): 301–307. PMID 11835035. doi:10.1067/mhj.2002.120768.
- ^ Packer M, Fowler MB, Roecker EB, Coats AJ, Katus HA, Krum H, et al. Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study. Circulation. October 2002, 106 (17): 2194–2199. PMID 12390947. doi:10.1161/01.CIR.0000035653.72855.BF .
- ^ Philip J Podrid, Philip J. Major side effects of beta blockers. UpToDate. 2023-06-15 [2024-03-22]. (
原始 内容 存 档于2024-03-24). - ^ Fletcher P. Beta blockers in heart failure. Australian Prescriber. 2000, 23 (6): 120–123 [2024-03-29]. doi:10.18773/austprescr.2000.138 . (
原始 内容 存 档于2023-06-06) (英 语). - ^ Use of beta-blockers and ivabradine in heart failure with reduced ejection fraction. www.uptodate.com. [2015-12-11]. (
原始 内容 存 档于2015-12-22). - ^ Pritchett AM, Redfield MM. Beta-blockers: new standard therapy for heart failure. Mayo Clinic Proceedings. August 2002, 77 (8): 839–845; quiz 845–46. PMID 12173717. doi:10.4065/77.8.839 .
- ^ Alabed S, Sabouni A, Al Dakhoul S, Bdaiwi Y. Beta-blockers for congestive heart failure in children. The Cochrane Database of Systematic Reviews. July 2020, 2020 (7): CD007037. PMC 7389334 . PMID 32700759. doi:10.1002/14651858.CD007037.pub4.
已 忽 略 未知 参 数 |collaboration=
(帮助) - ^ Goodman & Gilman's: The Pharmacological Basic of Therapeutics. McGraw-Hill. 2018. ISBN 9781259584732.
- ^ 22.0 22.1 22.2 22.3 22.4 Safi S, Sethi NJ, Nielsen EE, Feinberg J, Jakobsen JC, Gluud C. Beta-blockers for suspected or diagnosed acute myocardial infarction. The Cochrane Database of Systematic Reviews. December 2019, 12 (12): CD012484. PMC 6915833 . PMID 31845756. doi:10.1002/14651858.CD012484.pub2.
已 忽 略 未知 参 数 |collaboration=
(帮助) - ^ 23.0 23.1 Farzam K, Jan A. Beta Blockers. StatPearls. Treasure Island (FL): StatPearls Publishing. 2023 [2023-10-31]. PMID 30422501. (
原始 内容 存 档于2024-04-15). - ^ Iqbal AH, Jamal SF. Essential Hypertension. StatPearls. Treasure Island (FL): StatPearls Publishing. 2023 [2023-10-31]. PMID 30969681. (
原始 内容 存 档于2024-04-21). - ^ 25.0 25.1 Wong GW, Wright JM. Blood pressure lowering efficacy of nonselective beta-blockers for primary hypertension. The Cochrane Database of Systematic Reviews. February 2014, 2014 (2): CD007452. PMC 10603273 . PMID 24585007. doi:10.1002/14651858.CD007452.pub2.
已 忽 略 未知 参 数 |collaboration=
(帮助) - ^ 26.0 26.1 Wiysonge CS, Bradley HA, Volmink J, Mayosi BM, Opie LH. Beta-blockers for hypertension. The Cochrane Database of Systematic Reviews. January 2017, 1 (1): CD002003. PMC 5369873 . PMID 28107561. doi:10.1002/14651858.CD002003.pub5.
已 忽 略 未知 参 数 |collaboration=
(帮助). - ^ Schneier FR. Clinical practice. Social anxiety disorder. The New England Journal of Medicine. September 2006, 355 (10): 1029–1036. PMID 16957148. doi:10.1056/NEJMcp060145.
- ^ Tyrer P. Anxiolytics not acting at the benzodiazepine receptor: beta blockers. Progress in Neuro-Psychopharmacology & Biological Psychiatry. January 1992, 16 (1): 17–26. PMID 1348368. S2CID 24742562. doi:10.1016/0278-5846(92)90004-X.
- ^ Blessberger H, Lewis SR, Pritchard MW, Fawcett LJ, Domanovits H, Schlager O, et al. Perioperative beta-blockers for preventing surgery-related mortality and morbidity in adults undergoing cardiac surgery. The Cochrane Database of Systematic Reviews. September 2019, 9 (9): CD013435. PMC 6755267 . PMID 31544227. doi:10.1002/14651858.CD013435.
- ^ 30.0 30.1 30.2 Farzam, Khashayar; Jan., Arif. Beta Blockers. StatPearls. 2023-08-22 [2024-03-22]. (
原始 内容 存 档于2024-04-15). - ^ 31.0 31.1 31.2 31.3 31.4 31.5 Wyeth Pharmaceuticals Inc. Propranolol hydrochloride (PDF). [2020-09-03]. (
原始 内容 存 档 (PDF)于2021-03-08). - ^ National Heart, Lung, and Blood Institute. Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma–Summary Report 2007. The Journal of Allergy and Clinical Immunology. 2007, 120 (5): S94–S138 [2017-12-09]. doi:10.1016/j.jaci.2007.09.029 . (
原始 内容 存 档于August 28, 2021). - ^ Morales DR, Jackson C, Lipworth BJ, Donnan PT, Guthrie B. Adverse respiratory effect of acute
β -blocker exposure in asthma: a systematic review and meta-analysis of randomized controlled trials. Chest (Elsevier BV). April 2014, 145 (4): 779–786. PMID 24202435. doi:10.1378/chest.13-1235. - ^ Salpeter SR, Ormiston TM, Salpeter EE. Cardioselective beta-blockers in patients with reactive airway disease: a meta-analysis. Annals of Internal Medicine (American College of Physicians). November 2002, 137 (9): 715–725. PMID 12416945. doi:10.7326/0003-4819-137-9-200211050-00035 .
- ^ Sprague JE, Arbeláez AM. Glucose counterregulatory responses to hypoglycemia. Pediatric Endocrinology Reviews. September 2011, 9 (1): 463–475. PMC 3755377 . PMID 22783644.
- ^ Bertomeu-Gonzalez, Vicente; Moreno-Arribas, Jose. Increased Risk of Heart Failure in Elderly Patients Treated with Beta-Blockers After AV Node Ablation. American Journal of Cardiovascular Drugs. 2023-01-18 [2023]. doi:10.1007/s40256-022-00566-1. (
原始 内容 存 档于2024-03-24). - ^ Weinstein RS, Cole S, Knaster HB, Dahlbert T. Beta blocker overdose with propranolol and with atenolol. Annals of Emergency Medicine. February 1985, 14 (2): 161–163. PMID 2857542. doi:10.1016/S0196-0644(85)81081-7.
- ^ Toxicity, Beta-blocker: Treatment & Medication – eMedicine Emergency Medicine. [2009-03-06]. (
原始 内容 存 档于2009 -03-17). - ^ John Gualtier. Beta-Adrenergic Blocker Poisoning (PDF). Courses.ahc.umn.edu. [2017-03-28]. (
原始 内容 (PDF)存 档于2016-03-03). - ^ USMLE WORLD 2009 Step1, Pharmacology, Q85
- ^ Michel MC, Insel PA. Adrenergic Receptors in Clinical Medicine. Perez DM (编). The Adrenergic Receptors in the 21st Century. Humana Press. 2006: 135 [2010-09-08]. ISBN 978-1-58829-423-4.[
永久 失效 連結 ] - ^ Khan MI. Beta-Blockers. Encyclopedia of Heart Diseases. Elsevier. 2006: 160 [2010-09-10]. ISBN 978-0-12-406061-6. (
原始 内容 存 档于2023-01-14). - ^ Lamster IB, Northridge ME (编). Improving Oral Health for the Elderly: An Interdisciplinary Approach. New York: Springer. 2008: 87 [2010-10-23]. ISBN 978-0-387-74337-0. (
原始 内容 存 档于2023-01-14). - ^ Rothfeld GS, Romaine DS. Beta Antagonist (Blocker) Medications. The Encyclopedia of Men's Health. Amaranth. 2005: 48 [2010-10-23]. ISBN 978-0-8160-5177-9. (
原始 内容 存 档于2023-01-14). - ^ 45.0 45.1 Cojocariu SA, Maștaleru A, Sascău RA, Stătescu C, Mitu F, Leon-Constantin MM. Neuropsychiatric Consequences of Lipophilic Beta-Blockers. Medicina. February 2021, 57 (2): 155. PMC 7914867 . PMID 33572109. doi:10.3390/medicina57020155 .
- ^ Sir James Black, OM. The Telegraph. 2010-03-23 [25 March 2010]. (
原始 内容 存 档于2010-03-27). - ^ van der Vring JA, Daniëls MC, Holwerda NJ, Withagen PJ, Schelling A, Cleophas TJ, Hendriks MG. Combination of calcium channel blockers and beta blockers for patients with exercise-induced angina pectoris: a double-blind parallel-group comparison of different classes of calcium channel blockers. The Netherlands Working Group on Cardiovascular Research (WCN). Angiology. June 1999, 50 (6): 447–454. PMID 10378820. S2CID 21885509. doi:10.1177/000331979905000602.
- ^ Stapleton MP. Sir James Black and propranolol. The role of the basic sciences in the history of cardiovascular pharmacology. Texas Heart Institute Journal. 1997, 24 (4): 336–342. PMC 325477 . PMID 9456487.
- ^ Beta-Blockers–One Size Blocks Them All? Updates in Pharmacogenetic Education. AACP. [2024-03-24]. (
原始 内容 存 档于2024-03-24).
外部 連結
编辑
- Musicians and beta-blockers (页面
存 档备份,存 于互联网档案 馆) by Gerald Klickstein, 2010-03-11 (A blog post that considers "whether beta-blockers are safe, effective, and appropriate for performers to use.") - Better Playing Through Chemistry (页面
存 档备份,存 于互联网档案 馆) by Blair Tindall, The New York Times, 2004-10-17. (Discusses the use of beta blockers among professional musicians) - Musicians using beta blockers (页面
存 档备份,存 于互联网档案 馆) by Blair Tindall. A condensed version of the above article. - In Defense of the Beta Blocker (页面
存 档备份,存 于互联网档案 馆) by Carl Elliott, The Atlantic, 2008-08-20. (Discusses the use of propranolol by a North Korean pistol shooter in the 2008 Olympics) 醫學 主題 詞 表 (MeSH):beta-Adrenergic+Blockers